Gonadal cryopreservation in the young patient with gynaecological malignancy

Current Opinion in Obstetrics and Gynecology

Volumn 12, Issue 1, 2000, Pages 1-9

  Donnez, J ^a   Godin, P A ^a   Qu, J ^a   Nisolle, M ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CRYOPRESERVATION; EARLY MENOPAUSE; FEMALE; GYNECOLOGIC CANCER; HUMAN; INFERTILITY; NONHUMAN; OVARIECTOMY; OVARY FOLLICLE; OVARY FUNCTION; PRIORITY JOURNAL; REVIEW;

EID: 0034465512     PISSN: 1040872X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001703-200002000-00001     Document Type: Review

References (94)

1. The prevalence of cancer among adults in the United States
2. Pregnancy after human ovocyte cryopreservation
3. Birth after the cryopreservation of unfertilised ovocyte
4. Comparison of cryopreservation of supernumerary pronuclear human oocytes obtained after intracytoplasmic sperm injection (ICSI) and after conventional in-vitro fertilization
5. Pregnancy after immature oocyte donation and intracytoplasmic sperm injection
6. Birth of healthy female after intracytoplasmic sperm injection of cryopreserved human oocytes
7. Birth after cryopreservation of immature oocytes with subsequent in vitro maturation
8. Cryopreservation of human oocytes. A review of current problems and perspectives
9. Pathogenic activity of human oocytes following cryopreservation using 1,2-propandiol
10. Follicular development from ovarian xenografts in SCID mice
11. Low temperature storage and grafting of human ovarian tissue
12. Ovarian tissue cryopreservation for patients
13. Freezing ovary tissue may help cancer patients to preserve fertility
14. Freezing ovary tissue may help cancer patients preserve fertility
15. Effects of treatment on infertility in long term survivors of childhood or adolescent cancer
16. Pregnancy outcome after treatment for acute lymphoblastic leukemia during childhood or adolescence
17. Sentinel and other mutational effects in offspring of cancer survivors
18. Pregnancy outcome in patients treated for Hodgkin's disease
19. Indications for cryopreservation of ovarian tissue
20. Preserving fertility in early cervix carcinoma: Trachelectomy with laparoscopic lymphadenectomy
21. Conservative surgery plus adjuvant therapy for vulvovaginal rhabdomyosarcoma diethylstilbestrol clear cell adenocarcinoma of the vagina and unilateral germ cell tumors of the ovary
22. Borderline ovarian tumors
23. Results of fertility preserving operations in malignant ovarian tumors
24. Cytotoxic-induced ovarian failure in women with Hodgkin's disease. I. Hormone function
25. Female reproductive potential after treatment for Hodgkin's disease
26. The effect of combination chemotherapy on ovarian function in women treated for Hodgkin's disease
27. Uterine anomalies in Wilm's tumor survivors
28. Effects of cancer chemotherapy on gonadal function of patients
29. The effect of gonadal irradiation in clinical radiation therapy: A review
30. Pregnancy outcome in cancer patients. Experience in a large cooperative group
31. Radiosensitivity of mammalian oocyte with particular reference to the human female
32. The role of ovarian transposition in conservation of ovarian function in radical hysterectomy followed by pelvic radiation
33. The ovarian follicular apparatus
34. Follicular density in ovarian biopsy of infertile women: A novel method to assess the ovarian reserve
35. Effect of cryoprotectants on the survival of follicles in frozen mouse ovaries
36. Distribution and epidermal growth factor receptor expression of primordial follicles in human ovarian tissue before and after cryopreservation
37. Expression of receptors for insulin-like growth factor 1 and transforming growth factor β in human follicles
38. Histological and ultrastructural evaluation of fresh and frozen-thawed human ovarian xenografts in nude mice
39. A laparoscopic technique for obtaining ovarian cortical biopsy specimens for fertility conservation in patients with cancer
40. Isolation and characterization of primordial follicles from fresh and cryopreserved human ovarian tissue
41. Development of human primordial follicles to antral stages in SCID/hpg mice stimulated with follicle stimulating hormone
42. Restitution of fertility in sterilized mice by transferring primordial ovarian follicles
43. Immature rat ovaries become revascularized rapidly after autotransplantation and show a gonadotropin-dependent increase in angiogenic factor gene-expression
44. Human granulosa-luteal and cumulus cells express transforming growth factors-beta type 1 and type 2 mRNA
45. The secretion of transforming growth factor-beta by bovine luteal cells in vitro
46. Transforming growth factor-beta expression in the porcine ovary: Evidence that theca cells are the major secretory source during antral follicle development
47. Immunohistochemical localization of transforming growth factor-beta 1 and -beta 2 during follicular development in the adult rat ovary
48. Transforming growth factor-β1, insulin-like growth factor, and insulin-like growth factor binding proteins in ovarian follicular fluid are differentially regulated by the type of ovarian hyperstimulation used for in vitro fertilization
49. Secretion of transforming growth factor-beta (TGF-β) by porcine theca and granulosa cells in vitro and differential effects upon cell proliferation
50. Induction of apoptosis in rat thecal/interstitial cells by transforming growth factor-α plus transforming growth factor-β in vitro
51. The effect of transforming growth factor-β on follicle-stimulating hormone-induced differentiation of cultured rat granulosa cells
52. Transforming growth factor-β promotes differentiation of ovarian thecal/interstitial cells but inhibits androgen production
53. Transforming growth factor-beta inhibits ovarian 17 alpha-hydroxylase activity by a direct noncompetitive mechanism
54. Effect of transforming growth factors and inhibin-related proteins on rat preovulatory Graafian follicles in vitro
55. Ovarian transforming growth factor-β (TGF-β) receptors: In-vitro effects of follicle stimulating hormone, epidermal growth factor and TGFβ on receptor expression in human preantral follicles
56. Restoration of fertility to oophorectomized sheep by ovarian autografts stored at -196°C
57. Cryopreservation of marine ovarian tissue
58. Transplantation of cryopreserved fetal ovarian tissue to adult recipients in mice
59. Conservation of the follicular population in irradiated rats by the cryopreservation and orthotopic autografting of ovarian tissue
60. Freezing, thawing and autograft of ovarian fragments in sheep: Preliminary experiments and histologic assessment
61. Transplantation in reproductive medicine: Previous experience, present knowledge and future prospects
62. Fresh and cryopreserved ovarian tissue samples from donors with lymphoma transmit the cancer to graft recipients
63. Oncological implications in the replacement of ovarian tissue
64. Ovarian tissue banking in patients with Hodgkin's disease: Is it safe?
65. Ovarian banking for cancer patients: Transmission of malignant cells in ovarian grafts
66. Ovarian tissue cryopreservation: The time is now. Transplantation or in vitro maturation: The time awaits
67. The biology of follicular oocyte development in vitro
68. In vitro culture of ovarian follicles
69. Capacity of mouse oocytes from preantral follicles to undergo embryogenesis and development to live young after growth, maturation and fertilization in vitro
70. Mouse oocytes derived from in vitro grown primary ovarian follicles are fertile
71. In-vitro growth of oocyte-granulosa cell complexes isolated from cryopreserved ovine tissue
72. Isolation and long term culture of human preantral follicles
73. Mechanical isolation and in vitro growth of preantral and small antral human follicles
74. Cryopreservation of human ovarian tissue by using dimethylsulphoxide and proandiol-sucrose as cryoprotectants
75. Morphology and morphogenesis of the Stein-Leventhal ovary and so-called 'hyperthecosis'
76. Initiation in vitro of growth of bovine primordial follicles
77. Initiation of growth of baboon primordial follicles in vitro
78. Dynamics of follicular growth in the human: A model from preliminary results
79. Development of mouse follicles from primary to preovulatory stages in vitro
80. Development in vitro of mouse oocytes from primordial follicles
81. Extracellular matrix improves the survival of human primordial and primary fresh and frozenthawed ovarian follicles in long-term culture
82. Initiation of human primordial follicle growth in vitro in ultrathin slices of ovarian cortex
83. Oocyte in-vitro maturation and follicle culture: Current clinical achievement and future directions
84. Quantitative study of the development of isolated mouse pre-antral follicles in collagen gel culture
85. Isolation and preliminary characterization of pig primordial follicles
86. Response of granulosa cells isolated from primary and secondary follicles to FSH, 8-bromo-cAMP and epidermal growth factor in vitro
87. Effects of fetal bovine serum, FSH and 17β-estradiol on the culture of bovine preantral follicles
88. Radiotherapy after ovarian transposition: Ovarian function and fertility preservation
89. Pregnancies following high-dose cyclophosphamide with or without highdose busulfan or total body irradiation and bone narrow transplantation
90. Ovarian recovery after total body irradiation and allogenic transplantation: Long term follow-up of 79 females
91. Successful pregnancy after allogenic bone marrow transplantation for chronic myeloid leukemia
92. Permeation of human ovarian tissue with cryoprotective agents in preparation for cryopreservation
93. Preliminary experience with subcutaneous human ovarian cortex transplantation in the NOD-SCID mouse
94. New aspects of cryopreservation of oocytes and embryos in assisted reproduction and future perspectives